Spotting
 Timeline
 Travel Tip
 Trip
 Race
 Social
 Greeting
 Poll
 Img
 PNR
 Pic
 Blog
 News
 Conf TL
 RF Club
 Convention
 Monitor
 Topic
 #
 Rating
 Correct
 Wrong
 Stamp
 PNR Ref
 PNR Req
 Blank PNRs
 HJ
 Vote
 Pred
 @
 FM Alert
 FM Approval
 Pvt

RailCal app

site support

हम उस देश के वासी हैं, जिस देश में Shiv Ganga दौड़ती है

Search Forum
<<prev entry    next entry>>
Blog Entry# 4686429
Posted: Aug 12 2020 (22:23)

No Responses Yet
1703 views
1

Aug 12 2020 (22:23)  
Epiphany^~
Epiphany^~   13913 blog posts
Group Recipients: *current-affairs
Entry# 4686429              
GENERAL INFORMATION
Currently there are about 165 different vaccines for COVID-19 being developed around the world. The main types of vaccines include: viral vector-based vaccines, virus-based, nucleic acid-based and protein-based vaccines. Russian adenovirus vector-based vaccine was registered by the Russian Ministry of Health on August 11 and became the first registered COVID-19 vaccine on the market. The announcement created a so-called “Sputnik moment” for the global community.
In 1957 the successful launch of the first space satellite by the Soviet Union reinvigorated space research around the world. The new Russian COVID-19 vaccine is
...
more...
therefore called Sputnik V.
This website has been created to provide accurate and up-to-date information about Sputnik V and to combat the misinformation campaign launched against it in a number of the international media.
HOW ADENOVIRAL VECTOR-BASED VACCINES WORK
“Vectors” are vehicles, which can induce a genetic material from another virus into a cell. The gene from adenovirus, which causes the infection, is removed while a gene with the code of a protein from another virus spike is inserted. This inserted element is safe for the body but still helps the immune system to react and produce antibodies, which protect us from the infection.
The technological platform of adenovirus-based vectors makes it easier and faster to create new vaccines through modifying the initial carrier vector with genetic material from new emerging viruses that helps to create new vaccines in relatively short time. Such vaccines provoke a strong response from a human immune system.
Human adenoviruses are considered as some of the easiest to engineer in this way and therefore they have become very popular as vectors.
SAFETY AND EFFICACY
After the start of the COVID-19 pandemic Russian researchers extracted a fragment of genetic material from novel coronavirus SARS-COV-2, which codes information about the structure of the spike S-protein, which forms the virus’ “crown” and is responsible for connection with human cells. They inserted it into a familiar adenovirus vector for delivery into a human cell creating the world’s first COVID-19 vaccine.
In order to ensure lasting immunity Russian scientists came up with a breakthrough idea to use two different types of adenovirus vectors (rAd26 and rAd5) for the first and second vaccination, boosting the effect of the vaccine.
The use of human adenoviruses as vectors is safe because these viruses, which cause common cold, are not novel and have been around for thousands of years.

source url: click here

Translate to English
Translate to Hindi
Scroll to Top
Scroll to Bottom
Go to Desktop site
Important Note: This website NEVER solicits for Money or Donations. Please beware of anyone requesting/demanding money on behalf of IRI. Thanks.
Disclaimer: This website has NO affiliation with the Government-run site of Indian Railways. This site does NOT claim 100% accuracy of fast-changing Rail Information. YOU are responsible for independently confirming the validity of information through other sources.
India Rail Info Privacy Policy